Comunicati Stampa
Salute e Benessere

Qi Biodesign Completes $75 Million in Total Funding to Drive Genome Editing Innovations

Qi Biodesign has already achieved significant milestones in product development, including receiving two biosafety certificates for gene-edited plants (high oleic acid soybean and powdery mildew disease-resistant wheat) by the China Ministry of Agriculture and Rural Affairs and securing an exemption for a gene-edited product (high oleic acid soybean) from the US Department of Agriculture. More gene-edited traits including yield enhancements, herbicide tolerance and quality improvements are advancing through regulatory pipelines. Qi Biodesign's plant breeding innovations advance the application of gene editing in agriculture, contributing to food security and sustainable developments.
BEIJING, (informazione.news - comunicati stampa - salute e benessere)

Qi Biodesign has already achieved significant milestones in product development, including receiving two biosafety certificates for gene-edited plants (high oleic acid soybean and powdery mildew disease-resistant wheat) by the China Ministry of Agriculture and Rural Affairs and securing an exemption for a gene-edited product (high oleic acid soybean) from the US Department of Agriculture. More gene-edited traits including yield enhancements, herbicide tolerance and quality improvements are advancing through regulatory pipelines. Qi Biodesign's plant breeding innovations advance the application of gene editing in agriculture, contributing to food security and sustainable developments.

The newly secured funding will be used to enhance Qi Biodesign's R&D capabilities, advance its proprietary SEEDITâ„¢ platform, support its product development and build commercialization platforms to streamline and speed up the transition from research to market.

For more information, visit  http://www.qi-biodesign.com

CONTACT: Yihui Jiang , jyh@qi-biodesign.com 

View original content:https://www.prnewswire.co.uk/news-releases/qi-biodesign-completes-75-million-in-total-funding-to-drive-genome-editing-innovations-302324636.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili